SCHEMBL5362573

SCHEMBL5362573

Nc1ccnn1Cc1ccco1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 5/20 0.50
PKM P14618 1/20 0.50
ADORA2A P29274 2/20 0.47
ADORA1 P30542 2/20 0.47
TSHR P16473 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
ADORA2B P29275 1/20 0.44
CYP19A1 P11511 1/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 1/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
PSMD14 O00487 1/20 0.40
POLB P06746 1/20 0.40
MMP2 P08253 1/20 0.40
MAPT P10636 1/20 0.40
DNMT1 P26358 1/20 0.40
APEX1 P27695 1/20 0.40
PTPN7 P35236 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11063011 0.87 KDM4E (0.44) KDM4EALDH1A1PKMADORA2AADORA1
SCHEMBL4552901 0.86 KDM4E (0.45) KDM4EALDH1A1PKMADORA2AADORA1
SCHEMBL11323139 0.73 L3MBTL1 (0.56) KDM4EALDH1A1ADORA2AADORA1TSHR
SCHEMBL11699502 0.73 TSHR (0.58) KDM4EALDH1A1PKMADORA2AADORA1
SCHEMBL6760429 0.72 KDM4E (0.81) KDM4EALDH1A1PKMTSHRKMT2A
SCHEMBL568868 0.72 KDM4E (0.72) KDM4EALDH1A1PKMTSHRCYP19A1
SCHEMBL3555850 0.70
SCHEMBL6755827 0.69 KDM4E (0.57) KDM4EALDH1A1PKMKMT2AMAPK1
SCHEMBL11654507 0.69 KDM4E (0.58) KDM4EALDH1A1PKMLMNAPOLB
SCHEMBL1491110 0.68 KDM4E (1.00) KDM4EALDH1A1PKMTSHRCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US claimed
EP-1434552-A1 METHOD FOR DYEING KERATINOUS FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2004-07-07 EP claimed
WO-2003030841-A1 METHOD FOR DYEING KERATINOUS FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-04-17 WO claimed
US-11312722-B2 Hsp90 inhibitors and uses thereof TRUSTEES OF BOSTON UNIVERSITY (US) 2022-04-26 US disclosed
US-20200354373-A1 HSP90 INHIBITORS AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2020-11-12 US disclosed
EP-2753615-B1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2017-07-19 EP disclosed
US-8969335-B2 Benzonitrile derivatives as kinase inhibitors MERCK PATENT GMBH (DE) 2015-03-03 US disclosed
US-20140228340-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2014-08-14 US disclosed
CN-103930416-A Benzonitrile derivatives as kinase inhibitors MERCK PATENT GMBH 2014-07-16 CN disclosed
WO-2013034238-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS MERCK PATENT GMBH (DE) 2013-03-14 WO disclosed
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative L'OREAL S.A. 2007-06-14 US disclosed
EP-0036100-B1 NICKEL COMPLEX DYESTUFFS BASF Aktiengesellschaft (DE) 1983-06-15 EP disclosed
US-4246410-A BENZINDOLE DYES OF YELLOW AND RED CIBA -GEIGY AKTIENGESELLSCHAFT (CH) 1981-01-20 US disclosed
US-4115394-A ANTIINFLAMMATORY AGENTS, DIURETICS E. R. SQUIBB & SONS, INC. (US) 1978-09-19 US disclosed
US-3987051-A Method for producing 1-unsubstituted pyrazolo[3,4-b]pyridine ketones E. R. SQUIBB & SONS, INC. (US) 1976-10-19 US disclosed
US-3985757-A ANTIINFLAMMATORY AGENTS AND TRANQUILIZERS E. R. SQUIBB & SONS, INC. (US) 1976-10-12 US disclosed
US-3983128-A CNS DEPRESSANTS, ANTIINFLAMMATORY E. R. SQUIBB & SONS, INC. (US) 1976-09-28 US disclosed
US-3979399-A ATARACTIC, ANALGESIC, HYPOTENSIVE AGENTS E. R. SQUIBB & SONS, INC. (US) 1976-09-07 US disclosed
US-3966746-A ATARACTIC, ANALGESIC, HYPOTENSIVE E. R. SQUIBB & SONS, INC. (US) 1976-06-29 US disclosed
US-3957782-A Pyrazolo [3,4-b]pyrazine-5-carboxylic acids, esters, nitriles and amides E. R. SQUIBB & SONS, INC. (US) 1976-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070130702-A1 Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative KRT18, NDUFB5, NDUFB7 KDM4E 440/4885ALDH1A1 83/4885PKM 196/4885
US-20140228340-A1 BENZONITRILE DERIVATIVES AS KINASE INHIBITORS TBK1, NFKBIA, IKBKG KDM4E 347/4885ALDH1A1 3279/4885PKM 429/4885
US-20200354373-A1 HSP90 INHIBITORS AND USES THEREOF HSP90AB1, HSP90B1, HSP90AA1 KDM4E 1421/4885ALDH1A1 2482/4885PKM 3236/4885
US-11312722-B2 Hsp90 inhibitors and uses thereof HSP90AB1, HSP90B1, HSP90AA1 KDM4E 1421/4885ALDH1A1 2482/4885PKM 3236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.